Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells [Corrigendum]
Authors Obasi TC, Braicu C, Iacob BC, Bodoki E, Jurj A, Raduly L, Oniga I, Berindan-Neagoe I, Oprean R
Received 14 December 2018
Accepted for publication 14 December 2018
Published 15 January 2019 Volume 2019:11 Pages 691—692
Obasi TC, Braicu C, Iacob BC, et al. Cancer Manag Res. 2018;10:5709–5724.
On page 5717, there were errors in Figure 5A images and caption: the magnification is 40×, not 20×, and images 4A4 for Caski cells and 4A3 and 4A4 for Bu25TK cells have been replaced. The correct details follow.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]